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Background: Uncertainty in the levels of global maternal mortality reflects data deficiencies, 
as well as differences in methods and definitions. This study presents levels and trends in 
maternal mortality in Agincourt, a rural subdistrict of South Africa, under long-term health 
and sociodemographic surveillance.
Methods: All deaths of women aged 15 years–49 years occurring in the study area between 
1992 and 2010 were investigated, and causes of death were assessed by verbal autopsy. Two case 
definitions were used: “obstetrical” (direct) causes, defined as deaths caused by conditions listed 
under O00-O95 in International Classification of Diseases-10; and “pregnancy-related deaths”, 
defined as any death occurring during the maternal risk period (pregnancy, delivery, 6 weeks 
postpartum), irrespective of cause.
Results: The case definition had a major impact on levels and trends in maternal mortality. The 
obstetric mortality ratio averaged 185 per 100,000 live births over the period (60 deaths), whereas 
the pregnancy-related mortality ratio averaged 423 per 100,000 live births (137 deaths). Results 
from both calculations increased over the period, with a peak around 2006, followed by a decline 
coincident with the national roll-out of Prevention of Mother-to-Child Transmission of HIV 
and antiretroviral treatment programs. Mortality increase from direct causes was mainly due 
to hypertension or sepsis. Mortality increase from other causes was primarily due to the rise in 
deaths from HIV/AIDS and pulmonary tuberculosis.
Conclusion: These trends underline the major fluctuations induced by emerging infectious 
diseases in South Africa, a country undergoing rapid and complex health transitions.  Findings 
also pose questions about the most appropriate case definition for maternal mortality and 
emphasize the need for a consistent definition in order to better monitor and compare trends 
over time and across settings.
Keywords: maternal mortality, direct causes, pregnancy related deaths, Agincourt, South 
Africa
Introduction
Maternal mortality is a reflection of the state of public health and highly sensitive to 
targeted health interventions, both preventive and curative. For instance, in Sweden, 
maternal mortality was reduced 300-fold in two and a half centuries since 1750, 
because of better hygiene, better care, and innovative interventions during pregnancy, 
delivery, and the puerperium. Reducing maternal mortality by two thirds within 25 years 
(1990–2015) is the fifth “Millennium Development Goal” (MDG5a) set by the United 
Nations for low- and middle-income countries.1–5
Monitoring levels and trends in maternal mortality over a prolonged period was 
possible in European countries, because of comprehensive vital registration and cause 
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of death ascertainment; this is not the case in low- and middle 
income countries, particularly in sub-Saharan Africa. In fact, 
most estimates are from local studies (community-based or 
hospital-based), from demographic surveys (national  census 
or sample surveys), or occasionally from “confidential 
enquiries”. These sources have numerous biases and are 
rarely comparable because of varying population cover-
age and a lack of standard definition. The International 
 Classification of Diseases and Causes of Death, 10th revision 
(ICD-10) distinguishes three categories: the “direct causes”, 
which are obstetrical causes (listed under O00-O95 code); the 
so-called “indirect causes”, which are due to selected infec-
tious or noncommunicable causes assumed to be enhanced 
by the pregnancy (listed under O98-O99 code), and the 
“fortuitous causes”, which are assumed to be independent of 
the pregnancy. All deaths that occurred during the maternal 
risk period (pregnancy, delivery, up to 42 days after delivery) 
are known as the “pregnancy related deaths”. The situation 
was further complicated with the emergence of HIV/AIDS, 
now a major cause of death for women in their reproductive 
ages. The ICD-10 does not recommend including HIV/AIDS 
deaths among the indirect causes, but many analysts do, 
including the United Nations Maternal Mortality Estimation 
Inter-Agency Group.6–12
The case of South Africa is particularly interesting given 
the relatively extensive data on maternal mortality, the 
effects of the HIV/AIDS epidemic, and recent widespread 
introduction of Prevention of Mother-to-Child Transmission 
of HIV and antiretroviral therapy programs, and the apparent 
rapid increase in maternal mortality.13 A critical question 
is whether the mortality increase is due to deterioration in 
the quality of obstetric care or to the complex effects of 
emerging diseases on pregnancy outcome. Several papers 
have addressed this issue.14–24
This article presents an empirical analysis of maternal 
mortality over some 18 years in rural South Africa. It high-
lights the critical importance of case definition for monitoring 
levels and trends in maternal mortality, and in particular for 
evaluating “safe motherhood” and MDG5a. The study also 
demonstrates the large fluctuations created by the HIV/AIDS 
epidemic on women’s health.
Methods
The study was conducted in the Agincourt subdistrict of 
Mpumalanga Province, South Africa, adjacent to southern 
Mozambique, a rural setting under health and sociodemo-
graphic surveillance since 1992. The area covers a population 
of some 90,000 in 16,000 households, and was part of the 
former Gazankulu Bantustan or “homeland”, and is now in 
the Ehlangeni district. The district-based, nurse-led primary 
health care system includes a network of six clinics referring 
to a larger health center; three district hospitals are between 25 
and 60 km away. Most deliveries occurred in the health facili-
ties and antenatal care, and postnatal care is almost universal, 
although the quality of services is mixed. The  Agincourt study 
has been described in detail elsewhere.25–27
The health and sociodemographic surveillance system 
(HDSS) covers the subdistrict and includes comprehensive 
monitoring of household composition and vital events: births, 
deaths, in- and out-migrations, and detailed verbal autopsies 
to establish likely cause of death. The system was introduced 
in 1992/1993 and has been updated annually since then. Data 
for this study cover the period to July 2010 and include 18 
years of monitoring of vital events. Each year, well-trained 
fieldworkers visited every household in the study area, asked 
about vital events which had occurred since the last visit, 
and updated the household roster. In cases of death having 
occurred, a verbal autopsy was conducted with the closest 
caregiver of the deceased, by specially-trained lay fieldwork-
ers, in order to establish signs and symptoms of the terminal 
illness, lifestyle risk factors, and treatments. The interview 
was conducted using a 25-page comprehensive questionnaire 
(available on request from the authors), which included open 
and closed questions, and was written both in English and 
Shangaan, the local language.28 Completed questionnaires 
were independently reviewed by two physicians, who came 
to a consensus on the probable cause of death; a third physi-
cian assisted where the cause was disputed.28 Death regis-
tration was considered nearly complete, and verbal autopsy 
diagnoses were validated by comparing them with causes of 
death determined at hospital.29 The validation conducted in 
the early years, as well as more recently, indicated that all 
maternal deaths were correctly assessed by verbal autopsy, 
although the sample size was very small (six maternal deaths 
were compared with hospital diagnoses). Since the survey 
was conducted by interview with a close family member or 
community caregiver, there was no information on the HIV 
status of the deceased person. Mortality rates underwent 
major changes over the study period, with a marked increase 
between 1994 and 2006 due to the accelerating HIV/AIDS 
epidemic, and a decline since 2006 due to the extensive 
rollout and take-up of anti-retroviral therapy.28,30–33
All deaths of women aged 15 years–49 years that occurred 
among the resident population from 1992 to 2010 were 
investigated. Two definitions of maternal death were used: 
(1) “obstetrical” or “direct” causes (ICD10 code = O00 to O95) 
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(there were no late causes [O96-O97] in the sample); and (2) 
“any other cause” (indirect or fortuitous) that occurred during 
the maternal risk period. The total of (1) and (2) comprised 
all “pregnancy-related” deaths. We were not able to apply the 
World Health Organization’s definition for “indirect” causes 
because of the difficulty in determining whether a mortal-
ity outcome was “aggravated by the physiologic effects of 
pregnancy”. This is particularly important when appraising 
maternal deaths associated with human immunodeficiency 
virus (HIV)/acquired immunodeficiency syndrome (AIDS). 
In a companion paper, we explain that mortality from infec-
tious and parasitic diseases, or from noncommunicable 
diseases, was lower for pregnant women than nonpregnant 
women of the same age, so that no attributable risk could be 
assigned for indirect causes.34
There were missing values for the information on 
pregnancy (14%) and for causes of death (19%). Using 
an imputation method based on age at death, the possible 
undercount of the true number of maternal deaths was 
estimated at about 30% (32% for obstetric deaths, 28% 
for pregnancy-related deaths). However, for the sake of 
specificity, the analysis presented in this report was based 
only on the raw data, unadjusted for missing values.
Data were split into two periods: 1992/1993–2001 and 
2002–2010. The first period corresponded to the end of the 
fertility transition (fertility decline) and the beginning of the 
HIV/AIDS epidemic. The second period was marked by the 
massive increase in mortality caused by a peak in the linked 
epidemics of HIV/AIDS and pulmonary tuberculosis, followed 
by the introduction of highly active antiretroviral therapy. 
Relative risks (RR) compared the second period (2002–2010) 
with the first period (1992–2001) considered as the baseline. 
Standard statistical tests of RR were computed using Excel 2010 
(Microsoft Corporation, Redmond, WA, USA). The fitting of 
trends with polynomials was done using SPSS version16 (IBM 
Corporation, Armonk, NY, USA) linear logistic regression.
Results
Maternal mortality levels and trends
Since 1992/1993, the Agincourt study area hosted on average 
some 18,300 women aged 15 years–49 years. From the first 
to the second period (ie, 1992/1993–2001 to 2002–2010), 
the population increased by 19%, fertility declined by 19%, 
and mortality of women 15 years–49 increased 2.44- fold. 
Maternal mortality also doubled (RR = 2.08 for obstetrical 
causes, 95% confidence interval [CI] = 1.21–3.55; RR = 2.05 
for pregnancy-related deaths, 95% CI = 1.44–2.93); whereas 
the proportion of direct causes remained low and declined 
somewhat, from 3.6% to 2.5%. Most differences between the 
two periods were highly significant (Table 1).
The maternal mortality ratio (MMR), expressed per 
100,000 live births, was abnormally high and increasing. 
Table 1 Maternal mortality data, Agincourt, South Africa 1992–2010
Women 15–49 years Period RR 95% CI Significance
1992–2001 2002–2010
Raw data Person-years lived 150,091 178,757 1.19
Births 16,510 15,904 0.96
Deaths 15–49 555 1,615 2.91
Direct cause O00-O95 20 40 2.00
Pregnancy-related 46 91 1.98
Rates General fertility rate/1000 110 89 0.81 0.79–0.83 *
Death rate/1000 3.70 9.03 2.44 2.22–2.69 *
Percent direct 3.6 2.5 0.69 0.40–1.18 NS
MMR (direct)/100,000 121 252 2.08 1.21–3.55 *
MMR (Pregnancy-related)/100,000 279 572 2.05 1.44–2.93 *
Number of pregnancy-related deaths by cause (determined by verbal autopsy)
Direct Sepsis 2 9 4.67 1.01–21.6 *
Hypertension 3 8 2.77 0.73–10.4 NS
Other and ill defined 15 23 1.59 0.83–3.05 NS
Other HIV/AIDS, TB 9 26 3.00 1.41–6.40 *
Other infections 2 8 4.15 0.88–19.6 Borderline
Noncommunicable 4 5 1.30 0.35–4.83 NS
External 3 0 0.00 NS
Unknown cause 8 12 1.56 0.64–3.81 NS
Total 46 91 2.05 1.44–2.93 *
Notes: General fertility rate = births per 1,000 women age 15–49 per year; death rate = deaths per 1,000 women age 15–49 per year. *P , 0.05.
Abbreviations: CI, confidence interval; MMR, maternal mortality ratio (per 100,000 live births); NS, not significant; RR, relative risks; TB, tuberculosis.
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For obstetrical causes, MMR increased from 121 to 252 
per 100,000. For pregnancy-related deaths, MMR increased 
from 279 to 572 per 100,000. While a very high value, this 
appears consistent with national estimates from the 2001 cen-
sus and 2007 community survey (542 and 702 per 100,000, 
respectively).14–17
Trends in maternal mortality were not linear. As with gen-
eral mortality, maternal death rates first decreased over time 
then increased to a peak around 2006 before decreasing again. 
The changing rates were fitted with a third degree polynomial 
on individual data. The peak of obstetrical mortality could 
be as high as 300 per 100,000, and that of pregnancy-related 
mortality as high as 670 per 100,000 births, and potentially 
higher if missing values were included (Figure 1).
Causes of death
Despite the small number of cases, there was a pattern 
of change in the cause of death structure. For obstetri-
cal causes, 60% of the increase (12/20 deaths) was due to 
postpartum infections (RR = 4.67) and hypertensive causes 
(eclampsia/pre-eclampsia: RR = 2.77). The increase in mor-
tality from other causes (RR = 1.59) such as hemorrhage, 
obstructed labor, ectopic pregnancy, abortion, or obstetrically 
related pulmonary embolism was not statistically significant 
(Table 1).
Examining other causes (indirect and fortuitous) indicated 
that 92% of the increase (23/25 deaths) was due to HIV/AIDS, 
pulmonary tuberculosis, and other infections. In contrast, the 
contribution of deaths from noncommunicable diseases and 
external causes changed little (15 and 17 deaths respectively). 
Among the other infectious and parasitic causes, many were 
probably related to HIV/AIDS, notably septicemia (one 
case), meningitis (four cases), and pneumonia (one case); 
the remaining four cases were malaria deaths. Two-thirds 
of noncommunicable causes were cardiovascular diseases, 
the remainder were due to cancer of the female genital tract, 
asthma, and liver disease. The number of undetermined 
causes also increased but not in proportion to all deaths 
(17.4% and 13.2%, respectively).
Comparison with the confidential 
enquiries
The comparison with the confidential enquiries conducted 
since 1998 was difficult to perform. Firstly, the level of 
maternal mortality was different, since the confidential 
enquiries into maternal deaths (CEMD) recorded only 
maternal deaths in facilities with information on pregnancy. 
For instance, for the 2008–2010 period, the MMR for 
pregnancy-related deaths in the CEMD was 180 per 
100,000 in South Africa as a whole, and 174 per 100,000 in 
the Ehlanzeni district (where Agincourt is situated), whereas 
the HDSS recorded 603 per 100,000 during the same period 
(raw data) and 780 per 100,000 after correction for missing 
values. The CEMD records, therefore, accounted only for 
about a quarter of the pregnancy related deaths, which 
could lead to a selection bias. The CEMD indicated a steady 
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Figure 1 Trends in maternal mortality, Agincourt, subdistrict, South Africa 1992–2010.
Notes: National censuses were conducted in 2001 and 2007; census data apply to the 12 months before census. Vital registration data and confidential enquiries from 
published statistics (direct causes only). 
Abbreviation: MMR, maternal mortality ratio.
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increase in MMR over the years, both for pregnancy related 
deaths and for direct causes, probably because of increasing 
coverage over time, whereas Agincourt indicated ups and 
downs. The proportion of direct causes was essentially the 
same in the CEMD (48%) and in Agincourt (44%), and 
the small difference could be explained by the inclusion of 
external causes in Agincourt. The leading causes were also 
basically the same in Agicourt and in the CEMD, although the 
breakdown of the classification was not identical: the CEMD 
did not distinguish “obstructed labor”, whereas Agincourt 
does not have any category for “anesthetic related”, or “acute 
collapse”. Furthermore, in Agincourt, the coding of causes 
in the most recent period was not strictly identical to that 
done in earlier periods for hemorrhage. In terms of mortality 
increase, the trends were difficult to compare because 
Agincourt included a pre-AIDS baseline period (1992–2001), 
whereas the baseline for CEMD (1998–2001) was after the 
increase in AIDS mortality. In Agincourt, mortality doubled 
from 1992–2001 to 2002 –2010, whereas it increased only 
by 26% in the CEMD from 1999–2001 to 2002–2010. The 
strong increase in Agincourt for hypertensive disorders 
(RR = 2.77) and for sepsis (RR = 4.67) was larger than in 
the CEMD (RR = 1.20 and 1.15, respectively). The strong 
increase in hemorrhage in the CEMD (RR = 1.51) could 
not be verified in Agincourt because of coding inaccuracy 
after 2002. Only one category had a similar trend: ectopic 
pregnancy, miscarriage, and abortion increased similarly in 
Agincourt (RR = 1.30) and in the CEMD (RR = 1.32).
Discussion
The level of maternal mortality sustained in the Agincourt 
subdistrict was surprisingly high for a middle-income country 
like South Africa, as has been noted at national level.14 The 
level of obstetrical mortality documented corresponded to 
that of Sweden around 1900;1 while the level of pregnancy-
related deaths matched the highest levels recorded in African 
Demographic and Health Surveys.35 This occurred despite the 
relatively small proportion of deaths due to maternal causes 
in women 15 years–49 years, a fraction much lower than 
in comparable situations elsewhere.35 This is a new pattern 
which deserves further attention and has implications for 
mathematical models based on these proportions.
The Agincourt HDSS data include all maternal deaths 
that occurred in the study area population over the study 
period, irrespective of the place of death. They include 
deaths that occurred at home, in hospitals, en route for 
care, or elsewhere, and therefore the rates obtained from 
the demographic surveillance differ from those obtained by 
other methods, in particular from the confidential enquiries. 
Agincourt estimates also differ from the vital registration 
estimates, especially for pregnancy-related deaths. This is 
mainly due to the fact that the information on pregnancy is 
completed in only a small proportion of deaths of women age 
15 years–49 years (only 28% in the vital registration data for 
2006–2009). Improving the coverage of the vital registration 
system, as well as improving the entry of system forms, is 
crucial for rigorously monitoring the rapidly changing levels 
of maternal mortality. Studies such as the Agincourt HDSS 
contribute to understanding the weaknesses of current health 
information systems in South Africa.
The magnitude and speed of the changes in maternal 
mortality in Agincourt was outstanding. The first period 
(up to 1996) follows a standard pattern of mortality decline 
found in countries undergoing a health transition; the second 
period (1996–2006) witnessed a three-fold increase in about 
10 years, which is unique in the world; the speed of the 
decline after 2006 seems to be as rapid and as important. 
These changes appear to be a direct consequence of the 
dynamics of the HIV/AIDS epidemic, and seem unrelated to 
the quality of obstetric care. The magnitude of the changes 
makes it impossible to have a single estimate of MMR, 
and explains in part the confusion that arose about national 
estimates of MMR.
Trends in maternal mortality did not decline as might 
be expected given South Africa’s stated commitment to the 
MDG5a and the relatively high access to, and quality of, 
maternal health services. This disappointing pattern seems 
driven to a large extent by high levels of HIV/AIDS and 
tuberculosis. Arguably, the trends observed in MMR are no 
longer an indicator of safe motherhood, but simply a marker 
of the dynamics of evolving infectious disease epidemics.
The case definition was important in characterizing the 
level of maternal mortality. In fact, a lack of standardization 
can produce confusing estimates that range from 91 to 820 per 
100,000 at national level based on the same data but apply-
ing different case definitions and statistical methods.14 Our 
study underlines the need to better characterize “obstetrical 
causes,” and to adhere to a strict and consistent definition in 
order to monitor and compare trends over time and across 
different settings.
The basic structure of causes of maternal death observed 
in Agincourt, which include deaths in the community as well 
as in health facilities, does not seem to differ from that found 
in other sources in South Africa, although precise comparisons 
are difficult due to a lack of standardization and different data 
sources. Compared with the confidential enquiries into maternal 
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mortality, limited to health facility-deaths, the proportions and 
ranking of major causes were comparable for hypertensive 
disorders, hemorrhage, puerperal sepsis, abortion, and ectopic 
pregnancy.36 However, the proportion attributed to puerperal 
sepsis could be inflated in Agincourt by the inclusion of other 
infectious diseases related to HIV/AIDS, and this may explain 
why the increased mortality from these causes appeared more 
pronounced in Agincourt than in national data.
The indirect role of HIV/AIDS on the obstetrical causes 
needs further analysis. Since many of the classic obstetrical 
causes did not change over the years, one could attribute 
most of the change (infections and hypertension) to the direct 
and indirect effects of HIV/AIDS. Some of the increase in 
miscarriage and abortion could also be due to HIV/AIDS. 
The inclusion of some AIDS deaths among the deaths due 
to puerperal infection may be a diagnostic problem when 
coding causes of death in verbal autopsies. There is a need 
to examine this category by specific infectious cause, which 
remains difficult because of the small number of cases and 
lack of precision of verbal autopsies.
The increase in hypertensive disorders, also found in the 
confidential enquiries and in vital registration system data, 
deserves further research. While not due to HIV infection 
directly, this could be attributed to its treatment. Indeed, recent 
studies reported that highly active antiretroviral therapy could 
induce hypertension and potentially increase maternal mortality 
from pre-eclampsia and eclampsia. Active antiretroviral therapy 
may also have an effect on mortality from liver disease.37,38
In the context of a severe HIV epidemic such as that in 
Southern Africa, levels and trends in maternal mortality, even 
when restricted to obstetrical causes, no longer appear to be 
the exclusive indicators of the quality of obstetric care. This 
perspective is critical when monitoring change and trends 
in MDG5a and interpreting their significance for policy and 
programs relating to sexual and reproductive health and safe 
motherhood.
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